Activist investor Bill Ackman, who once attacked multi-level marketing company Herbalife on the grounds that it was an illegal pyramid scheme, has sworn off future short selling campaigns.
Rice Bran Technologies has exited the Brazilian market and will concentrate on growing its ingredients business in North America, the company announced recently.
ChromaDex Corp has been the target of a short seller whose allegations against the company caused the company’s stock price to stagger. CEO Frank Jaksch called the attack ‘baseless.’
ChromaDex, which has generated a raft of positive news in recent months, has reached another milestone by clearing the bar to be listed on the Nasdaq stock exchange.
MusclePharm Corporation, a sports nutrition firm noted for its aggressive marketing via athlete endorsements, continues its meteoric growth curve even as the company required additional funding earlier this year and the stock price continues to fall.
Dietary supplements retailer Natural Grocers by Vitamin Cottage said it has seen strong sales growth in supplements driven by its in-store education efforts.
The management team at supplement manufacturer Nutranomics has turned over in an effort to reinvigorate a company that has lost sales momentum and whose stock price has declined precipitously.
Youngevity International, a company that is both a network marketing firm that sells nutritional and personal care products and a vertically integrated gourmet coffee roaster, reported a 57% increase in annual net revnue amid plans to expand its geographical...
Activist investor Bill Ackman has released a new video attack that takes nutritional products network marketing giant Herbalife to task over non-compliant disease treatment claims made for the products on the part of distributors. The company responded...
Network marketing giant Herbal reported sales growth but missed analysts’ expectations for earnings in its third quarter of 2014. Part of the earnings miss was caused by the steep devaluation of Nicaragua’s currency and so was characterized by management...
Herbalife's share price dropped sharply yesterday as the company reported second quarter earnings that missed analysts’ estimates. Shares dropped 11% almost immediately on the news and declined further in early trading today, with a share price...
Neptune Technologies and Bioressources, the pioneer in the krill oil sector, has reported a second quarter loss as it recovers from the destruction of its sole production facility. The company will have some work to do to regain market share once it...
Krill oil producer Neptune Technologies and Bioressources has been slapped with two additional class action shareholders’ rights lawsuits and another two law firms have announced investigations into whether the company has violated securities laws.
Neptune Technologies and Bioressources has been hit with a shareholder rights lawsuit over the Nov. 8 explosion and fire that destroyed the company’s production facility and a resulting steep decline in the company’s share price.
The consumer arm of German pharma giant Bayer Healthcare is to pay $1.2bn (€920m) for US food supplements company Schiff Nutrition International, a move that will make it one of the biggest operators there, feed product development globally, and may not...
Norwegian krill specialist Aker BioMarine is set to merge with Aker Seafoods Holding after winning board approval, a move prompted by the intended divestment of a major investor.
US chemical group DuPont has successfully completed its tender offer for Danisco, as 92.2 percent of outstanding shares in the Danish food ingredients firm were tendered by Friday’s deadline, DuPont said on Monday.
The parent company of General Nutrition Centers (GNC) Inc has begun trading on the New York Stock Exchange, joining rival Vitamin Shoppe, which went public in late 2009.
Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...
Danisco is to be snapped up by DuPont for $6.3bn, in a deal Dupont says could create a global leader in industrial biotech – and help drive science-based solutions to the world’s food and fuel challenges.
ChromaDex Corporation has announced a rise in revenue for the third quarter of 2010 of $1,562,352, compared with $1,433,086 in Q3 2009, but increased expenses related to marketing and further development of the pTeroPure product line led to a net loss.
Glanbia Plc is poised to become a more US focused nutrition business with the financial freedom to grow rapidly but Irish farmers could still pull the plug on the deal announced to the media today.
UK-based start-up Provexis has signed a Letter of Intent with its biggest shareholder, DSM, that will give the nutritional products division of the Dutch company exclusive global rights to Provexis’s tomato extract Fruitflow technology.
Reports of my death have been greatly exaggerated, quipped Mark Twain. Predictions of the demise of Cadbury following the approval of Kraft’s offer are premature and are flawed by knee-jerk anti-Americanism.
Rumour, according to the Romans, is a feathered beast with a myriad eyes and tongues. Last week she went bristling through the Danish business pages, spreading the news that Danisco could be bought by a private equity firm.
Neptune Technologies and Bioressources is taking steps to increase
its liquidity on the NASDAQ exchange and stimulate interest in the
company from health-savvy US investors.
Norwegian fish oil producer EPAX is to be acquired by compatriot
Austevoll Seafood - a move that will give it a vertically
integrated supply from fishing to omega-3 oil supply and avoid
potential sourcing problems for the future.
Cyanotech has been threatened with being bumped from Nasdaq's
SmallCap market if its share price does not rise above the minimum
$1.00 for 10 consecutive days before the end of May 2006.
UK natural healthcare firm William Ransom said today that it will
buy Optima Healthcare, the UK market leader in aloe vera brands,
and its Irish subsidiary for £23 million (€34.3m), reports
Dominique Patton.
A public share offering by Malaysian company Hovid this week will
help its subsidiary Carotech, the supplier of palm-derived vitamin
E products, grow its business.
German group Cognis, the supplier of plant sterols and CLA, is
considering the issue of a €500 million bond to fund a dividend
payment to its private equity owners, it said last week.
Australian vitamin and drug maker Lipa Pharmaceuticals plans to
raise A$67 million (€38.2m) from an initial public offering of
shares, which will fund expansion of the company's manufacturing
plant to meet growing customer demand.
Canadian firm Forbes Medi-Tech saw shares jump 10 per cent this
week following the announcement by the European Food Safety Agency
(EFSA) that its cholesterol-lowering ingredient Reducol is safe.
Hawaiian firm Cyanotech has yet again managed to stave off a
delisting from the Nasdaq SmallCap market, meeting requirements for
the bid price of $1 per share for a consecutive 10 days in recent
months.
Leading Irish food ingredients company Kerry brushed off currency
fluctuations and testing market conditions to post a stable set of
figures for the first six months of the year. The following paper
from Irish stockbroker Goodbody...
Two years after the company went public, $20 billion US oilseed
giant Bunge declares a regular quarterly cash dividend of $0.11 per
share following swiftly on from strong second quarter earnings
announced in July this year.
Danish food ingredients group Danisco has denied rumours
circulating in the local press that it is in talks to sell its
stake in US biotech company Genencor.
The largest US maker of fish oils Omega Protein said today it had
received a letter containing an acquisition proposal from Ferrari
Investments of Comodoro Rivadava, Argentina, and an unidentified US
partner.
Ambitious company Vital Living has merged with privately held
nutraceutical-based drug development company Enhanced
Nutriceuticals (ENI). The deal gives pharma drug-delivery company
SkyePharma - a shareholder of ENI - a slice of Vital...
The world's top cocoa processor, Swiss-based Barry Callebaut, said
on Tuesday that it had suspended efforts to take full control of
chocolate maker Stollwerck after minority shareholders in the
German firm filed a lawsuit against...
